首页 | 本学科首页   官方微博 | 高级检索  
     

表皮生长因子受体信号通路在人子宫内膜癌移植瘤孕激素耐药机制中的作用
引用本文:徐妍力,王娟,艾志宏,滕银成. 表皮生长因子受体信号通路在人子宫内膜癌移植瘤孕激素耐药机制中的作用[J]. 上海交通大学学报(医学版), 2011, 31(1): 21-25. DOI: 10.3969/j.issn.1674-8115.2011.01.005
作者姓名:徐妍力  王娟  艾志宏  滕银成
作者单位:上海交通大学附属第六人民医院妇产科,上海,200233
基金项目:上海市科委基金(07ZR14059); 国家自然科学基金(30801229)~~
摘    要:目的建立人子宫内膜癌皮下移植瘤孕激素耐药模型,探讨表皮生长因子受体(EGFR)下游信号通路在子宫内膜癌孕激素耐药机制中的作用。方法分别利用人子宫内膜癌孕激素敏感型Ishikawa细胞株和孕激素不敏感型Ishikawa-pLWERNL细胞株制备裸鼠皮下移植瘤模型(每组18只);成瘤后,分别将接种Ishikawa细胞株和接种Ishikawa-pLWERNL细胞株的裸鼠各自分成3组(每组6只),分别给予甲羟孕酮(MPA组)、吉非替尼(吉非替尼组)、生理盐水(对照组)。疗程结束后称取各组肿瘤湿重,采用Western blotting法检测肿瘤组织中EGFR、孕激素受体B(PR-B)、ERK1/2、p-ERK1/2、AKT及p-AKT蛋白的表达。结果在接种Ishikawa细胞株的裸鼠中,MPA组、吉非替尼组移植瘤湿重与对照组相比,分别减轻43.0%和31.5%,差异有统计学意义(P均<0.05)。在接种Ishikawa-pLWERNL细胞株的裸鼠中,吉非替尼组移植瘤湿重与对照组相比,减轻35.7%,差异有统计学意义(P<0.05);而MPA组移植瘤湿重与对照组相比,减轻2.9%,差异无统计学意义(P>0.05)。接种I...

关 键 词:人子宫内膜癌移植瘤  表皮生长因子受体信号通路  孕激素受体B  孕激素耐药  吉非替尼

Role of epidermal growth factor receptor signaling pathway in progestin resistance of human endometrial carcinoma xenografts
XU Yan-li,WANG Juan,AI Zhi-hong,TENG Yin-cheng. Role of epidermal growth factor receptor signaling pathway in progestin resistance of human endometrial carcinoma xenografts[J]. Journal of Shanghai Jiaotong University:Medical Science, 2011, 31(1): 21-25. DOI: 10.3969/j.issn.1674-8115.2011.01.005
Authors:XU Yan-li  WANG Juan  AI Zhi-hong  TENG Yin-cheng
Affiliation:XU Yan-li,WANG Juan,AI Zhi-hong,TENG Yin-cheng(Department of Obstetrics and Gynecology,The Sixth People's Hospital,Shanghai Jiaotong University,Shanghai 200233,China)
Abstract:Objective To establish progestin-resistant models of human endometrial carcinoma xenografts,and explore the role of epidermal growth factor receptor(EGFR) signaling pathway in progestin resistance of human endometrial carcinoma xenografts.Methods Thirty-six nude mice were subcutaneously injected with human endometrial carcinoma progestin-sensitive Ishikawa cells(n=18) or progestin-insensitive Ishikawa-pLWERNL cells(n=18),and human endometrial carcinoma xenografts were formed.Then,both nude mice treated with...
Keywords:human endometrial carcinoma xenografts  epidermal growth factor receptor signaling pathway  progesterone receptor B  progestin resistance  gefitinib  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《上海交通大学学报(医学版)》浏览原始摘要信息
点击此处可从《上海交通大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号